Nomocan Pharmaceuticals LLC
Pharmaceutical company · Brooklyn, New York, United States
Nomocan Pharmaceuticals LLC is a pharmaceutical company headquartered in Brooklyn, New York, United States. Its earliest recorded incorporation is in 2014. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $854,125 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $740,000 sold in a notice filed in 2015.
Nomocan Pharmaceuticals at a glance
What does Nomocan Pharmaceuticals do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $854,125 in total (2023 to 2025).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $740,000 sold (2015).
Frequently asked questions about Nomocan Pharmaceuticals
Where is Nomocan Pharmaceuticals headquartered?
Nomocan Pharmaceuticals LLC is headquartered in Brooklyn, New York, United States.
What does Nomocan Pharmaceuticals do?
Nomocan Pharmaceuticals LLC is a pharmaceutical company.
When was Nomocan Pharmaceuticals founded?
The earliest incorporation on record for Nomocan Pharmaceuticals LLC is in 2014, according to public company registers.
Similar companies
- Serenity Pharmaceuticals LLCBrooklyn, New York, United States
- Pierrepont Therapeutics, Inc.Brooklyn, New York, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences